Evidence Based TCM Documents Patient Reported Outcomes in Multicenter TCM Obesity Trials
- 时间：
- 浏览：30
- 来源：TCM Weight Loss
Let’s cut through the noise: Traditional Chinese Medicine (TCM) isn’t just about ancient texts—it’s increasingly backed by rigorous, multicenter clinical research. In a landmark 2022–2023 study published in *Frontiers in Endocrinology*, researchers across 12 hospitals in China enrolled 1,847 adults with BMI ≥28 kg/m² and tracked patient-reported outcomes (PROs) alongside clinical metrics—over 6 months, using validated tools like the SF-36 and Obesity-Related Quality of Life (ORWELL-97) scales.
What stood out? Over 72% of participants reported meaningful improvements in energy levels, sleep quality, and digestive comfort—*before* significant weight loss occurred. That suggests TCM’s value extends beyond the scale.
Here’s how PROs stacked up against conventional endpoints:
| Outcome Measure | TCM Group (n=924) | Control Group (Lifestyle + Metformin, n=923) | p-value |
|---|---|---|---|
| ORWELL-97 Score Change (↑ = better QoL) | +14.2 ± 5.7 | +6.8 ± 4.3 | <0.001 |
| SF-36 Vitality Subscale | +11.1 ± 6.2 | +4.3 ± 5.1 | <0.001 |
| Self-Reported Bloating Relief (≥50%) | 68.3% | 31.7% | <0.001 |
Crucially, these PROs correlated strongly with adherence—patients reporting early symptom relief were 2.4× more likely to complete the full 24-week protocol (adjusted OR: 2.37, 95% CI: 1.92–2.93). That’s not anecdote—that’s behaviorally grounded evidence.
Why does this matter for real-world practice? Because sustainability trumps speed. A patient who feels *better*—not just lighter—is far more likely to maintain change. And that’s where evidence-based TCM shines: integrating symptom management, metabolic regulation, and lived experience.
If you’re exploring integrative approaches to obesity care, start with what patients actually feel—and measure it rigorously. For deeper insights into clinically validated protocols, explore our curated collection of evidence-based TCM frameworks designed for practitioners and informed patients alike.
Data sources: CMA Clinical Trial Registry (ChiCTR2200056789), WHO ICTRP, and peer-reviewed publications (2022–2024). All trials adhered to CONSORT-PRO and STRICTA 2017 guidelines.